Wellington Management Group
NMRA icon

Wellington Management Group’s Neumora Therapeutics NMRA Stock Holding History

Wellington Management Group’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,187
Closed -$195K – 1943
2024
Q1 		$195K Buy
+14,187
New +$229K ﹤0.01% 1875

Other funds holding NMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group's NMRA Position: Q2 2024 in Review

Wellington Management Group sold out of Neumora Therapeutics (NMRA) in Q2 2024, closing a stake of 14,187 shares — an estimated $195K sold.

Wellington Management Group first reported a position in NMRA in Q1 2024 and held it in 1 quarter. The position peaked at $195K in Q1 2024. 93 funds tracked by Wall St. Rank hold NMRA as of Q2 2024.

  • Wellington Management Group reported no remaining Neumora Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 14,187 Neumora Therapeutics shares in Q2 2024, an estimated $195K.
  • Wellington Management Group first reported a position in Neumora Therapeutics in Q1 2024 and held it in 1 quarter.
  • Wellington Management Group's Neumora Therapeutics position peaked at $195K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.